Cited by 16Genetics and Neurodevelopmental DisordersFetal and Pediatric Neurological DisordersGenomics and Rare Diseases

Novel EXOSC3 pathogenic variant results in a mild course of neurologic disease with cerebellum involvement

Le Duc, Diana, Horn, Susanne, Jamra, Rami Abou, Schaper, Jörg, Wieczorek, Dagmar, Redler, Silke·2020·European Journal of Medical Genetics

Abstract

EXOSC3-related autosomal recessive neurodevelopmental disorders are rare entities with variable clinical course and prognosis. They are characterized by hypoplasia of cerebellar structures and pons, degeneration of the anterior horn cells and motor as well as neurocognitive impairment. Phenotypic expression is variable with an overall poor outcome. Current research suggests clear genotype-phenotype correlations among EXOSC3-pathogenic-variants carriers. Homozygosity for the EXOSC3 variant c.395A > C, p.(Asp132Ala) is proposed to lead to a rather mild phenotype compared to compound-heterozygous EXOSC3-pathogenic-variants carriers with lethal neurological disease in very early childhood. In this study, we report two siblings (21- and 8-year-old) affected by PCH1B with an unusual presentation. We identified compound heterozygosity for the well-established EXOSC3 variant c.395A > C, p.(Asp132Ala) and the novel variant c.572G > A, p.(Gly191Asp), expanding the genetic spectrum. Phenotypic presentation of the siblings was strikingly different from that of literature reports with a surprisingly mild disease manifestation and an unexpected intrafamilial variability. This study demonstrates the extensive clinical heterogeneity and the broad phenotypic spectrum associated with EXOSC3-associated disorders. Enlargement of sample sizes and reports of novel cases will be essential for the delineation of associated phenotypes.

Integrity signals

Registry

Crossref · 10.1016/j.ejmg.2019.04.006

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PCH1B patients who are carriers of compound heterozygous EXOSC3 D132A/G191D variants present with milder disease, without involving the pons, and show intrafamilial variability.

    “PCH1B patients who are carriers of compound heterozygous EXOSC3 D132A/G191D variants present with milder disease, without involving the pons, and show intrafamilial variability23,53,54.”
  • The lesser thermodynamic severity of the G191C variant compared to G191D correlates well with less severe clinical outcomes observed in G191C homozygous patients compared to G191D homozygous patients.

    “Notably, the lesser thermodynamic severity of the G191C variant compared to G191D correlates well with less severe clinical outcomes observed in G191C homozygous patients (previously classified with complicated hereditary spastic paraplegia) compared to G191D homozygous patients (classified with moderate PCH1b) 23,53,54.”
  • These findings could potentially explain the observation of intrafamily variability of EXOSC3 G191 variant associated disease severity.

    “These findings could potentially explain the observation of intrafamily variability of EXOSC3 G191 variant associated disease severity54.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Le Duc, D., Horn, S., Jamra, R. A., Schaper, J., Wieczorek, D., & Redler, S.
Affiliations
  • Leipzig University (DE)
  • Heinrich Heine University Düsseldorf (DE)
Corresponding author
Redler, Silke
Venue
European Journal of Medical Genetics
Publisher
Elsevier BV
Published
2020-02
Volume
63
Issue
2
Pages
103649
ISSN
1769-7212 (ISSN-L)
OpenAlex
W2937366904
Cited by
16
References
15
Citations by year
2026: 4 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 4 · 2020: 3
FWCI
1.35
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Medical Genetics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Fetal and Pediatric Neurological Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
EXOSC3, autosomal recessive neurodevelopmental disorder, compound heterozygosity, novel pathogenic variant, cerebellar hypoplasia, anterior horn cell degeneration, genotype-phenotype correlation, intrafamilial variability, clinical heterogeneity, phenotypic spectrum
MeSH terms
Cerebellar Diseases, Cerebellum, Child, Female, Heterozygote, Homozygote, Humans, Male, Mutation, Phenotype, RNA-Binding Proteins, Siblings, Young Adult, Genetic Association Studies, Exosome Multienzyme Ribonuclease Complex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review